ARWR

Arrowhead Pharmaceuticals Stock Analysis

AI Rating

Great
  • Quality7/10
  • Growth↑ 9/10
  • Momentum↑ 9/10
Arrowhead Pharmaceuticals sales and earnings growth
ARWR Growth
Great
  • Revenue Y/Y↑ 43539.24%
  • EPS Y/Y↑ 130.23%
  • FCF Y/Y↑ 156.33%
Arrowhead Pharmaceuticals gross and profit margin trends
ARWR Profitability
Good
  • Gross margin ↑ 100.00%
  • EPS margin↑ 18.50%
  • ROIC↑ 17.70%
Arrowhead Pharmaceuticals net debt vs free cash flow
ARWR Risk
Good
  • Debt / Equity↓ 1.2
  • Debt / FCF↓ 1.5
  • Interest coverage↓ 3.5

Arrowhead Pharmaceuticals stock volatility is higher than the overall market. We give it a Good risk rating.

More Biotechnology stocks ↗